Ability Pharma
-
DATABASE (48)
-
ARTICLES (111)
American investment capital firm Farallon Capital Management was established in 1986. The company manages equity capital for institutions, including college endowments, charitable foundations and pension plans, and funds for high net worth individuals. While most of its investments are in risk arbitrage and debt restructuring, it has also invested in startups across different verticals, such as Indonesian ride-hailing firm Gojek and a host of biotechnology, pharmaceuticals and medical technology companies.Farallon’s history with Indonesia began long before Gojek came into existence. In 2002, Farallon bought a controlling stake in Bank Central Asia (BCA), an Indonesian bank, during a time when investors avoided Indonesian banks that had been saddled with bad debt. With the controlling stake, Farallon installed a new bank chairman and reformed BCA. Over the next four years Farallon slowly divested in BCA and finally sold the remaining 4% stake in 2006 to earn a profit.
American investment capital firm Farallon Capital Management was established in 1986. The company manages equity capital for institutions, including college endowments, charitable foundations and pension plans, and funds for high net worth individuals. While most of its investments are in risk arbitrage and debt restructuring, it has also invested in startups across different verticals, such as Indonesian ride-hailing firm Gojek and a host of biotechnology, pharmaceuticals and medical technology companies.Farallon’s history with Indonesia began long before Gojek came into existence. In 2002, Farallon bought a controlling stake in Bank Central Asia (BCA), an Indonesian bank, during a time when investors avoided Indonesian banks that had been saddled with bad debt. With the controlling stake, Farallon installed a new bank chairman and reformed BCA. Over the next four years Farallon slowly divested in BCA and finally sold the remaining 4% stake in 2006 to earn a profit.
TI Platform Management is a US-based investment firm founded by Alex Bangash and Trang T Nguyen, who are also the founders of LP network and investment news platform TrustedInsight. Founded in 2015, the firm seeks out disruptive business models and invests in a range of categories, from furniture and home construction to healthcare and deep-tech. It has invested in Singapore-based enzyme engineering startup Allozymes, B2B pharmacy fulfillment service TruePill, and supply chain management startup Tyltgo.
TI Platform Management is a US-based investment firm founded by Alex Bangash and Trang T Nguyen, who are also the founders of LP network and investment news platform TrustedInsight. Founded in 2015, the firm seeks out disruptive business models and invests in a range of categories, from furniture and home construction to healthcare and deep-tech. It has invested in Singapore-based enzyme engineering startup Allozymes, B2B pharmacy fulfillment service TruePill, and supply chain management startup Tyltgo.
Founded in Hong Kong in 2018, Lake Bleu Capital currently operates in both Hong Kong and Shanghai. With assets worth billions of US dollars under management, it mainly invests in pharmaceuticals, biotech, medical devices and healthcare services companies in Asia, especially Greater China. Its limited partners include sovereign wealth funds, university endowments, foundations, pension funds, and family offices across the world.With a long-term investment strategy, Lake Bleu Capital invests through both public and private equity with a focus on mid- to late-stage companies.
Founded in Hong Kong in 2018, Lake Bleu Capital currently operates in both Hong Kong and Shanghai. With assets worth billions of US dollars under management, it mainly invests in pharmaceuticals, biotech, medical devices and healthcare services companies in Asia, especially Greater China. Its limited partners include sovereign wealth funds, university endowments, foundations, pension funds, and family offices across the world.With a long-term investment strategy, Lake Bleu Capital invests through both public and private equity with a focus on mid- to late-stage companies.
Daniel Oliver: Building a "Facebook" for investments in biotech startups
The biologist and crowdfunding expert has pioneered the growth of Spanish biotech startups, providing access to early-stage investments, with support from scientific experts worldwide
South Summit 2021: Martin Varavsky, Leandro Sigman on post-Covid healthcare trends
Serial entrepreneur Martin Varavsky and Insud Pharma Chairman Leandro Sigman share their thoughts and projections on the future of health tech
TurtleTree Labs: Creating sustainable mammalian milk alternatives from stem cells
Founder’s search for high-quality dairy milk led to the creation in a lab of naturally occurring ingredients found in human milk for supply to dairy milk and infant formula businesses
Gorry Holdings: Promoting staff wellness in Indonesia
The healthtech startup wants companies to understand how healthy employees can translate into good business
Animal AgTech Innovation Summit 2021: Experts discuss post-pandemic priorities
The pandemic not only put digital tech in everyone’s hands, it also forced thinking about collecting meaningful data and moving it on-demand to both producers and decision makers
How Sequoia Capital China is helping its portfolio startups get through the Covid-19 crisis
The renowned investor is also making big bets on the opportunities that lie head
Meatable joins Royal DSM to create growth media specific for cell-based meat tech
The R&D between the biotech startup and fellow Dutch nutrition conglomerate could help scale and drive the commercial viability of lab-grown meat
Backed by pharmas, doctors, medtech startup DyCare is expanding fast across Europe
Its remote musculoskeletal rehabilitation and monitoring system sets to improve rehabilitation outcomes in an overtaxed sector
iLoF: Accelerating access to personalized medicine, from a drop of blood
Backed by Microsoft’s venture fund M12, Mayfield and Melinda Gates’s Pivotal Ventures, iLoF focuses on painless screening to facilitate disease detection, forecasting and drug development, from Alzheimer’s to Covid-19
Biomilq: Creating cell-based mothers’ milk in a lab
With the aim of helping women struggling to breastfeed, Bill Gates-backed Biomilq is disrupting the $45bn baby formula industry developing lab-grown breast milk from mammary epithelial cells
IOMED: Delivering structured, extractable patient big data and helping Spain's Covid-19 response
The medtech cuts the time spent on finding candidates for medical research by 90% and last month secured €2m in seed funding to take its software overseas
Singapore, the place to start and grow a cellular agriculture startup
A country that imports over 90% of its food supply, Singapore has turned to foodtech, including cellular agriculture, to safeguard food security, supported by proactive regulators
Sound Particles: the CGI for sound effects taking Hollywood by storm
This revolutionary 3D audio software has propelled Portuguese founder Nuno Fonseca from teaching music to credits in Star Wars, Game of Thrones and Frozen II.
New Food Invest: Challenges of growing an alt-protein startup
Founders of three alt-protein startups in the US share what motivated them to start, their personal experiences growing the businesses, getting funding and finding strategic partners
This app lets you show off your cat on social media
Is Meowcard the next big thing or a flash in the pan?
Sorry, we couldn’t find any matches for “Ability Pharma”.
